Clinical Trials List
2008-05-01 - 2011-08-15
Phase II
Terminated4
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Pin-Nan Cheng Division of General Internal Medicine
- 吳毅晉 Division of General Internal Medicine
- 陳炳誠 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 胡琮輝 Digestive System Department
- 紀廣明 Digestive System Department
- Jing-Houng Wang Digestive System Department
- Chen-Hua Liu Digestive System Department
- 陳建宏 Digestive System Department
- 洪肇宏 Digestive System Department
- Chun-Jen Liu Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming-Lung Yu Digestive System Department
- Jee-Fu Huang Digestive System Department
- Chia-Yen Dai Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 賴明陽 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
600 participants
